Cargando…
Seizing the strategic opportunities of emerging technologies by building up innovation system: monoclonal antibody development in China
BACKGROUND: Monoclonal antibodies (mAbs), as an emerging technology, have become increasingly important in the development of human therapeutic agents. How developing countries such as China could seize this emerging technological opportunity remains a poorly studied issue in prior literature. Thus,...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634786/ https://www.ncbi.nlm.nih.gov/pubmed/26537659 http://dx.doi.org/10.1186/s12961-015-0056-1 |